📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-01 15:41
0 analysed today
FollowTelegram
0
Today
151,433
All-time analysed
43,376
Positive
6,732
Negative
92,513
Neutral
8,744
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
Southern Magnesium: AGM Rejects Designation Change of N. Rajender Prasad as MD & CFO
Southern Magnesium & Chemicals reported that at its 40th AGM held on September 30, 2026, shareholders did not approve the resolution redesignating Mr. Nuthakki Rajender Prasad from Joint Managing Director & CFO to Managing Director & CFO due to insufficient votes. Consequently, Mr. Prasad will continue in his existing role as Joint Managing Director and CFO on previous terms approved at the 39th AGM until August 09, 2028. The company has a small scale of operations, generating Rs 3 Cr in TTM revenue with a market capitalization of Rs 24 Cr.
Confidence: HIGH
What changedShareholders rejected the elevation of N. Rajender Prasad to Managing Director & CFO, leaving him in his current role of Joint Managing Director & CFO.
Why it mattersIndicates shareholder pushback on board resolutions despite promoter holding of 50.94%, though executive leadership remains unchanged.
AGM Date: 30th September, 2026Tenure End Date: 09.08.2028Promoter Holding: 50.94%TTM Revenue: Rs 3 Cr
📅 Short termLimited direct impact on operations since Mr. Prasad continues managing the business under his existing role.
📈 Long termLimited operational change, though governance dynamics and shareholder voting behavior warrant tracking.
⚠ Risk flags
- Shareholder dissent on board resolutions
- Small operating scale and negative TTM operating margins (-9.3%)
Key Highlights
AGM held on September 30, 2026 did not approve redesignation of N. Rajender Prasad as MD & CFO due to insufficient votes
Continues in existing role as Joint Managing Director and CFO as approved at 39th AGM held on September 29, 2025
Current tenure runs for the period from August 10, 2025 to August 09, 2028
Company market cap stands at Rs 24 Cr against TTM revenue of Rs 3 Cr
👀 What to Watch
Monitor voting pattern details in the scrutiny report to understand institutional or public shareholder dissent, along with upcoming Q2 FY27 operational performance.
Southern Magnesium Reports Q1 Loss of ₹0.50 Cr; Revenue at ₹0.32 Cr
Southern Magnesium & Chemicals reported a net loss of ₹50.01 lakhs for the quarter ended June 30, 2026, a significant widening from the ₹9.86 lakhs loss in the same period last year. Revenue from operations stood at ₹31.54 lakhs, which is a 45% increase YoY but a 65% decline sequentially from the March 2026 quarter. Total expenses of ₹88.53 lakhs significantly exceeded the total income of ₹39.05 lakhs, resulting in a negative EPS of ₹1.67. The company has scheduled its 40th Annual General Meeting for September 30, 2026.
Confidence: HIGH
What changedThe company has swung back to a significant loss after a marginally profitable March 2026 quarter, with revenue falling sharply on a sequential basis.
Why it mattersFor a micro-cap company with a market cap of only ₹22 Cr and TTM revenue of ₹3 Cr, consistent operating losses pose a risk to its net worth and long-term viability.
Revenue (Q1 FY27): ₹31.54 lakhsNet Loss (Q1 FY27): ₹50.01 lakhsEPS (Q1 FY27): -₹1.67Revenue vs TTM Revenue: ~10.5%AGM Date: 30.09.2026
📅 Short termThe stock is likely to face downward pressure due to the poor quarterly performance and widening losses.
📈 Long termThe company's long-term outlook remains weak unless it can significantly scale its magnesium business to achieve operational break-even.
⚠ Risk flags
- Operating losses
- Small scale of operations
- High finance costs relative to revenue
Key Highlights
Net loss widened to ₹50.01 lakhs in Q1 FY27 compared to a loss of ₹9.86 lakhs in Q1 FY26
Revenue from operations grew 45% YoY to ₹31.54 lakhs from ₹21.70 lakhs
Total expenses rose to ₹88.53 lakhs, driven by employee benefits (₹15.57 lakhs) and other expenses (₹32.84 lakhs)
Finance costs remained high at ₹9.53 lakhs relative to the small revenue base
Book closure for the 40th AGM is set for September 24, 2026, to September 30, 2026
👀 What to Watch
Investors should monitor the company's ability to scale operations, as current revenue levels are insufficient to cover fixed costs. Watch for management's strategy at the upcoming AGM on September 30 to address the widening losses.
Rs 0.50 Cr Net Loss in Q1 FY27 as Expenses Double YoY
Southern Magnesium & Chemicals reported a widening net loss of Rs 50.01 lakhs for the quarter ended June 30, 2026, compared to a loss of Rs 9.86 lakhs in the same period last year. While revenue from operations grew 45% YoY to Rs 31.54 lakhs, it was completely offset by a 94% surge in total expenses, which reached Rs 88.53 lakhs. The quarterly loss is significant for this micro-cap, representing approximately 16.7% of its TTM revenue of Rs 3 crore. The company has scheduled its 40th Annual General Meeting for September 30, 2026.
Confidence: HIGH
What changedThe company's financial health deteriorated in Q1 FY27 as expense growth (94%) far outpaced revenue growth (45%), leading to a five-fold increase in quarterly net loss.
Why it mattersFor a micro-cap company with a market capitalization of only Rs 22 Cr, consistent losses and a very small revenue base (Rs 3 Cr TTM) pose a high risk to capital preservation and indicate a lack of operational scale.
Net Loss (Q1 FY27): Rs 50.01 lakhsRevenue from Operations: Rs 31.54 lakhsTotal Expenses: Rs 88.53 lakhsLoss vs TTM Revenue: ~16.7%AGM Date: 30.09.2026
📅 Short termThe stock is likely to face downward pressure due to the widening losses and the high expense-to-revenue ratio reported this quarter.
📈 Long termLimited; the company remains a micro-cap with stagnant revenue growth and persistent profitability challenges in the industrial minerals sector.
⚠ Risk flags
- Widening net losses
- High expense volatility
- Micro-cap liquidity risk
- Small revenue scale relative to fixed costs
Key Highlights
Net loss widened significantly to Rs 50.01 lakhs from Rs 9.86 lakhs in Q1 FY26
Revenue from operations increased 45.3% YoY to Rs 31.54 lakhs from Rs 21.70 lakhs
Total expenses surged to Rs 88.53 lakhs, nearly double the Rs 45.63 lakhs reported in the previous year's quarter
Other expenses saw a sharp rise to Rs 32.84 lakhs from Rs 10.75 lakhs YoY
Book closure for the 40th AGM is fixed from September 24, 2026, to September 30, 2026
👀 What to Watch
Investors should monitor the upcoming AGM on September 30, 2026, for management's explanation regarding the sharp increase in 'Other Expenses' and the strategy to scale revenue beyond the current low base.
₹50.01 Lakh Net Loss: Southern Magnesium Reports Widening Losses in Q1 FY27
Southern Magnesium & Chemicals reported a net loss of ₹50.01 lakhs for the quarter ended June 30, 2026, significantly higher than the ₹9.86 lakh loss in the same period last year. While revenue from operations grew 45% YoY to ₹31.54 lakhs, it plummeted 65% sequentially from ₹89.86 lakhs in the March 2026 quarter. Total expenses of ₹88.53 lakhs were more than double the total income of ₹39.05 lakhs, driven by a sharp rise in other expenses. The company's small scale (₹22 Cr market cap) makes it highly sensitive to these operational losses.
Confidence: HIGH
What changedThe company transitioned from a marginal profit in the previous quarter to a significant loss, with expenses now far outstripping total income.
Why it mattersFor a micro-cap company with TTM revenue of only ₹3 Cr, a quarterly loss of ₹0.5 Cr is highly material and indicates severe operational inefficiency or lack of scale.
Net Loss (Q1 FY27): ₹50.01 lakhsRevenue from Operations: ₹31.54 lakhsRevenue vs TTM Revenue: 10.51%Total Expenses: ₹88.53 lakhsEPS (Basic/Diluted): ₹-1.67
📅 Short termThe stock is likely to face downward pressure as the widening loss and high expense ratio reflect poor operational health.
📈 Long termThe company's long-term viability depends on its ability to recover its revenue base, which has shrunk significantly from FY25 levels.
⚠ Risk flags
- Operating expenses exceeding total income
- Significant sequential revenue decline
- Small scale of operations making it vulnerable to fixed costs
Key Highlights
Net loss widened to ₹50.01 lakhs compared to a loss of ₹9.86 lakhs in June 2025.
Revenue from operations fell 64.9% sequentially to ₹31.54 lakhs from ₹89.86 lakhs in Q4 FY26.
Other expenses surged to ₹32.84 lakhs, a 205% increase compared to ₹10.75 lakhs in the year-ago quarter.
Total expenses of ₹88.53 lakhs significantly exceeded the total income of ₹39.05 lakhs.
The 40th Annual General Meeting (AGM) is scheduled for September 30, 2026.
👀 What to Watch
Investors should monitor the 'Other expenses' line item and the company's ability to scale revenue back toward FY25 levels (₹12.43 Cr) to achieve operational break-even.
